Armistice Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-88,000
| Closed | -$9.05M | – | 301 |
|
2023
Q2 | $9.05M | Sell |
88,000
-120,000
| -58% | -$12.3M | 0.13% | 95 |
|
2023
Q1 | $22.7M | Buy |
+208,000
| New | +$22.7M | 0.33% | 54 |
|
2018
Q2 | – | Sell |
-1,540,000
| Closed | -$21.9M | – | 89 |
|
2018
Q1 | $21.9M | Buy |
1,540,000
+540,000
| +54% | +$7.67M | 1.67% | 23 |
|
2017
Q4 | $14.6M | Buy |
1,000,000
+200,000
| +25% | +$2.92M | 1.46% | 21 |
|
2017
Q3 | $10.1M | Sell |
800,000
-20,000
| -2% | -$254K | 1.19% | 27 |
|
2017
Q2 | $9.73M | Sell |
820,000
-30,000
| -4% | -$356K | 1.24% | 29 |
|
2017
Q1 | $12.6M | Buy |
850,000
+200,000
| +31% | +$2.96M | 2.59% | 14 |
|
2016
Q4 | $10.5M | Buy |
+650,000
| New | +$10.5M | 2.49% | 11 |
|
2016
Q3 | – | Sell |
-400,000
| Closed | -$6.59M | – | 59 |
|
2016
Q2 | $6.59M | Buy |
+400,000
| New | +$6.59M | 2.51% | 11 |
|